The rare disease drugs market is experiencing remarkable growth driven by innovations in gene therapies, RNA-based drugs, biologics, and precision medicine. In 2025, the global rare disease market size is estimated to be around $242.5 billion to $244.6 billion and is expected to nearly double or more, reaching between $374 billion and over $495 billion by the early 2030s, with a...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek